Vanderbilt-Ingram Cancer Center (VICC) has launched its new Personalized Cancer Medicine Initiative, becoming the first cancer center in the Southeast and one of the first in the nation to offer cancer patients routine “genotyping” of their tumors at the DNA level.
Currently, decisions on how to treat most forms of cancer are based on morphological evidence and do not take into consideration any genetic factors. Nonetheless, a large body of evidence exists showing that how a patient or certain form of cancer responds to treatment may be dependent on the genetic make-up of the specific tumor. With this in mind, Vanderbilt has developed an electronic medical record system which matches the patient’s tumor genotype against a cancer tumor database and suggests a course of treatment that is most appropriate for that specific tumor.
Be sure to visit the Vanderbilt-Ingram Cancer Center’s website to read more about their Personalized Cancer Medicine Initiative.